Showing results (11-20 of 207) with videos related to

Sort By:
Pageof 21
AIDS Research and Human Retroviruses|October 17, 2020
IFNL4 Genotype Does Not Associate with CD4 T-Cell Recovery in People Living with Human Immunodeficiency VirusEric G Meissner, Dongjun Chung, Betty Tsao, et al.
Drug Development Research|June 10, 2021
Potential use of serum-derived bovine immunoglobulin/protein isolate for the management of COVID-19Netanya S Utay, David M Asmuth, Shahin Gharakhanian, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Impact of intestinal parasitic infections on gut epithelial barrier and inflammation among foreign-born persons living with HIVMelissa Reimer-McAtee, Jose Serpa, Casey McAtee, et al.
Transgender Health|October 25, 2024
Transgender Women with HIV Demonstrate Unique Non-Alcoholic Fatty Liver Disease ProfilesJordan E Lake, Ana N Hyatt, Han Feng, et al.
Current Opinion in HIV and AIDS|July 12, 2011
Generalized immune activation and innate immune responses in simian immunodeficiency virus infectionSteven E Bosinger, Donald L Sodora, Guido Silvestri
The American Journal of Tropical Medicine and Hygiene|September 30, 2025
Impact of Intestinal Parasitic Infections on Gut Epithelial Barrier and Inflammation among Foreign-Born Persons Living with HIVMelissa Reimer-McAtee, Jose Serpa, Casey L McAtee, et al.
AIDS Research and Human Retroviruses|June 28, 2016
Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected PeopleMeena Sunil, Maitreyee Nigalye, Anoma Somasunderam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2022
Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV)Kara W Chew, Kunling Wu, Katherine Tassiopoulos, et al.
Journal of Medical Virology|October 11, 2024
Serum-derived bovine immunoglobulin treatment in COVID-19 is associated with faster resolution of symptoms: A randomized pilot clinical trialNetanya S Utay, Roberto Güerri-Fernández, Shahin Gharakhanian, et al.
Oncotarget|December 2, 2017
The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cellsHolly C Lewis, Raghavan Chinnadurai, Steven E Bosinger, et al.
Pageof 21